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 Abstract 26 
Background: Studies of the effect of vitamin B12 and folate on risk of asthma and hay fever 27 
have shown inconsistent results that may be biased by reverse causation and confounding. 28 
We used a Mendelian randomization approach to examine a potential causal effect of vitamin 29 
B12 and folate on hay fever, asthma, and selected biomarkers of allergy by using eleven 30 
vitamin B12-associated single nucleotide polymorphisms (SNPs) and two folate-associated 31 
SNPs as un-confounded markers.  32 
Methods: We included 162,736 participants from nine population-based studies including 33 
the UK Biobank. Results were combined in instrumental variable and meta-analyses and 34 
effects expressed as odds ratios (ORs) or estimates with 95% confidence interval (CI).  35 
Findings: Using genetic proxies for B12 and folate, instrumental variable analyses did not 36 
show evidence for associations between serum B12 and hay fever: OR=1.02 (95% CI: 0.98, 37 
1.05), asthma: OR=0.99 (95% CI: 0.95, 1.04), allergic sensitization: OR=1.02 (95% CI: 0.74, 38 
1.40), or change in serum IgE: 10.0% (95% CI: -9.6%, 29.6%) per 100 pg/ml B12. Similarly 39 
there was no evidence for association between serum folate and hay fever: OR=0.74 (95% 40 
CI: 0.45, 1.21), asthma: OR=0.80 (95% CI: 0.43, 1.49), allergic sensitization: OR=1.92 (95% 41 
CI: 0.11, 33.45), but there was a statistically significant association with change in serum 42 
IgE: 2.0% (95% CI: 0.43%, 3.58%) per 0.1 ng/ml serum folate.  43 
Conclusions: Our results did not support the hypothesis that levels of vitamin B12 and folate 44 
are causally related to hay fever, asthma, or biomarkers of allergy, but we found evidence of 45 
a positive association between serum folate and serum total IgE. 46 
 47 
Keywords: allergic disease, serum specific IgE, hay fever, rhinitis, asthma, allergic 48 
sensitization.49 
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 Introduction 50 
Changes in dietary intake of micronutrients such as vitamin B12 and folate have been 51 
suggested to play a role in the increase in allergic respiratory diseases (1-4). Low intake and 52 
low serum levels of folate are common, particularly in countries without food fortification 53 
with folic acid (5). Folate deficiency changes the cell-mediated immune response (6) and 54 
increases the susceptibility to infections (7), and folate deficiency might also directly 55 
contribute to the development of atopy by inhibiting the re-methylation cycle in humans (4). 56 
On the other hand, in mice, a diet enriched with folate was shown to increase allergic 57 
responses, likely through epigenetic changes (8).  58 
 Inferring causal relationships in observational studies may be hampered by 59 
reverse causation and confounding. Mendelian randomization is a method to examine 60 
possible causal relationships where genetic variants with known effects on an exposure are 61 
used as proxies for that exposure (9). It is based on an assumption that alleles are randomly 62 
allocated from parent to child, thus mimicking a randomized controlled trial potentially free 63 
from confounding and reverse causation (10,11).  64 
 There are different designs for Mendelian randomization studies (12). Some 65 
provide evidence on whether a causal association exists. Others allow the magnitude of the 66 
causal effect to be estimated; for example, in the two-sample approach the SNP-exposure 67 
associations are estimated in non-overlapping samples (12). In this study we used available 68 
serum B12- and folate-associated single nucleotide polymorphisms (SNPs), e.g., a SNP in the 69 
methylene-tetrahydrofolate reductase (MTHFR) that affects serum levels of folate (13,14). If 70 
the assumptions of Mendelian randomization analysis are met, these genetic proxies for B12 71 
and folate levels unlike serum B12 and folate levels should not be associated with the 72 
confounders that may distort the associations. Our primary aim was to test the causal nature 73 
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 of the association of vitamin B12 and folate with hay fever, asthma, allergic sensitization, and 74 
serum total IgE, by performing a Mendelian randomization analysis of the effect of eleven 75 
vitamin B12-associated SNPs and two folate-associated SNPs. We also aimed to quantify any 76 
such effects in a two-sample instrumental variable analysis. 77 
  78 
Materials and Methods 79 
Study populations 80 
We used data on 162,736 participants of European ancestry from the following nine 81 
population-based studies: the Allergy98 Cohort (15), the Danish Monitoring of trends and 82 
determinants in Cardiovascular Diseases study (the Monica10 study) (16), Health2006 (17), 83 
Health2008 (15), Inter99 (18), the 1936 Cohort (19), the Study of Health in Pomerania 84 
(SHIP) (20), and SHIP-TREND (21), and the UK Biobank (22) (see Supplementary 85 
Material). The studies were approved by local Ethics Committees, and participants gave their 86 
informed consent. Prior to the study, we performed a number of power calculations. For 87 
example, for the B12-associated SNP-score, a sample of approximately 142,600 persons of 88 
which approximately 1 in 7 have hay fever would allow us to detect a causal effect odds ratio 89 
of 0.93 for hay fever per standard deviation higher B12 with a power of 0.80 and a 90 
significance level of 0.05. This corresponds to an odds ratio of 0.94 per 100 pmol/l higher 91 
vitamin B12. 92 
 93 
Genotype 94 
We included the B12- and folate-associated SNPs listed in Table 2 (23) (more information in 95 
Supplementary Material). The selection was based on a previous study that found eight novel 96 
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 loci associating with levels of B12 and folate and confirmed another seven loci for these traits 97 
(23). The SNPs were classified according to the number of B12/folate increasing alleles.   98 
 99 
Exposure 100 
Serum vitamin B12 and folate were measured in the SHIP-TREND, Health2006, and 101 
Health2008 Study by chemiluminescent immunoassay (Dimension Vista platform, Siemens 102 
Healthcare Diagnostics GmbH, Eschborn in Germany), in the Inter99 by competitive 103 
chemiluminescent enzyme immunoassays (IMMULITE 2000 System, Siemens Healthcare 104 
Diagnostics, Deerfield, IL, USA).  105 
 106 
Outcome 107 
Information on asthma and hay fever was based on self-report (Table S4). Allergic 108 
sensitization was defined as specific IgE positivity (specific IgE ≥0.35 kU/l) to at least one of 109 
a number of relevant inhalant allergens (Table S4). Serum total IgE was measured with 110 
IMMULITE 2000 Allergy Immunoassay System in the Allergy98 and Inter99 Study, and by 111 
the Latex IgE test on the BN II Nephelometer (Dade Behring Marburg GmbH, Marburg, 112 
Germany) in the SHIP Study (24) (Supplementary Material). 113 
  114 
Statistical analyses 115 
Statistical analyses were performed with SAS, version 9.4 (SAS Institute Inc., Cary, NC, 116 
USA), and STATA, version 12 and 13 (StataCorp, College Station, TX, USA), and R version 117 
3.3.3 (RStudio). Code can be made available on request. The reported P-values are two-118 
tailed, and statistical significance was defined as P<0.05. The included SNPs were 119 
preselected. We combined the 13 included single-SNP estimates in meta-analyses across 120 
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 study populations and across SNPs in the main analyses rather than using a SNP-score. To 121 
comply with requirements of normality, serum total IgE was log-transformed in the 122 
regression analyses.   123 
 All reported regression analyses were adjusted for sex and age. Observational 124 
analyses of the associations of vitamin B12 and folate and hay fever, asthma, allergic 125 
sensitization, and serum total IgE were assessed by logistic and linear regression analyses. 126 
The associations of each of the 13 SNPs with vitamin B12 and folate and with hay fever, 127 
asthma, allergic sensitization, and serum total IgE were assessed using linear and logistic 128 
regression. For each SNP, the single SNP estimates from each study were meta-analyzed 129 
using the ‘metan’ command in Stata. The meta-analyzed single SNP estimates were then 130 
combined in instrumental variable and fixed-effects meta-analyses. Heterogeneity was 131 
examined by the I2.   132 
 In the two-sample IV analysis, the SNP-exposure estimates were calculated in 133 
the four studies that had data on B12 and folate. SNP-outcome estimates were performed in 134 
the five studies with no data on B12 and folate. We used the inverse-variance weighted (ivw) 135 
estimator for the B12- and folate-analyses with the “mregger” command in Stata, and the 136 
“mr_ivw” package in R (25), respectively. To make the IV analyses of the binary outcomes 137 
comparable with the observational analyses, the estimates and CIs were expressed per 100 138 
pg/ml change in B12 and per 10 ng/ml change in folate. For the binary B12-analyses, we also 139 
performed MR Egger regression analyses to test for pleiotropy (12). 140 
 In sensitivity analyses, we investigated the associations of the B12- and folate-141 
associated SNPs excluding SNPs with low SNP-exposure F-value which is an indicator of 142 
power in MR studies (data not shown) (26). In further analyses, we assessed unweighted, 143 
weighted, and standardized SNP-scores (Table 2). The individual weights were derived from 144 
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 a study population different from our own (23). Associations of B12-associated SNP-scores 145 
and log2 transformed serum vitamin B12 and folate in both simple and weighted B12 and 146 
folate SNP-scores were tested including only studies with data on ≥12 SNPs (SHIP, Inter99, 147 
Health2006, Monica10, and UK Biobank. In addition, we examined the association between 148 
SNP-scores and hay fever and asthma in different samples of the UK Biobank, i.e. genetically 149 
vs. self-reported European ancestry, and in the Bileve sample vs. the rest, when further 150 
adjusted for income, body mass index, alcohol intake, and smoking habits (Table S5-S6 and 151 
figure S1-S6). 152 
 153 
Results 154 
Observational analyses 155 
Descriptive statistics for the study populations are shown in Table 1. In total, we had data on 156 
162,736 participants. Serum vitamin B12 was not associated with higher risk of hay fever: 157 
odds ratio (OR) =1.01 (95% confidence interval [CI]: 0.96, 1.07), asthma: OR=1.01 (95% CI: 158 
0.95, 1.07), or allergic sensitization: OR=1.02 (95% CI: 0.98, 1.03) per 100 pg/ml higher 159 
serum vitamin B12 (Figure 1). Increasing folate was associated with a higher odds of allergic 160 
sensitization: OR=1.09 (95% CI: 1.02, 1.16), but not with risk of hay fever: OR=1.05 (95% 161 
CI: 0.97, 1.13) and asthma: OR=0.99 (95% CI: 0.90, 1.09) per 10 ng/ml higher folate (Figure 162 
2).  163 
 Vitamin B12 was positively and significantly associated with serum total IgE 164 
with a 4.0% (95% CI: 0.2%, 8.0%, p=0.041) change in total IgE per 100 pg/ml higher serum 165 
vitamin B12 (Figure 3). There was no clear evidence for an association between serum folate 166 
and serum total IgE with a 0.04% (95% CI: -0.05%, 0.14%) change in serum total IgE per 167 
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 0.10 ng/ml higher serum folate. In general, the heterogeneity between studies was low and 168 
ranged from 0.0-14.6% according to I2.  169 
Genetic analyses 170 
All SNPs were independent and did not deviate from Hardy-Weinberg equilibrium 171 
(Bonferroni-adjusted significance level 0.0005). Our results confirmed that the vitamin B12 172 
and folate-associated alleles were associated with an increase in serum levels of vitamin B12 173 
and folate (except for rs652197). We kept this SNP, since the SNP was preselected because it 174 
was confirmed as an instrument for folate in a previous study (23).  175 
 F-values for the associations between each serum B12- or folate-associated SNP 176 
and serum vitamin B12 and folate, respectively, are shown in Supplementary Table S3. The 177 
F-values were reasonably strong and well above ten for the most part. However, for the 178 
rs778805, rs1047891, and rs652197 SNPs, the F-values were quite low, and they were 179 
excluded in sensitivity analyses (explained below). In UK Biobank, the associations between 180 
the genetic B12 and folate scores and hay fever and asthma were largely similar when they 181 
were adjusted for age, sex, BMI, household income, alcohol intake, and smoking status as 182 
opposed to just age and sex. 183 
 Fixed effects meta-analyses of the age- and sex-adjusted associations between 184 
serum vitamin B12 or folate associated SNPs and the outcomes showed no evidence of a 185 
causal effect of B12 on hay fever: OR=1.01 (95% CI: 1.00, 1.01), asthma: OR=1.00 (95% CI: 186 
0.99, 1.00), allergic sensitization: OR=0.99 (95% CI: 0.96, 1.01), and a 1.0% (95% CI: -187 
1.0%, 2.0%) change in serum total IgE per B12-increasing allele. Results of corresponding 188 
analyses for serum folate were for hay fever: OR=0.99 (95% CI: 0.97, 1.01), asthma: 189 
OR=0.99 (95% CI: 0.97, 1.01), allergic sensitization: OR=1.02 (95% CI: 0.97, 1.08), and a 190 
4.0% (95% CI: 0.4%, 7.0%) change in serum total IgE per folate-increasing allele.  191 
 9 
  Mendelian randomization analyses of the associations of scores of the B12- or 192 
folate associated SNPs excluding SNPs with low F-values left the estimates almost 193 
unchanged. Simple and weighted B12 and folate SNP-scores were similar when including 194 
only studies with data on ≥12 SNPs. Genetic analyses in different UK Biobank samples 195 
showed no substantial differences.  196 
 197 
Instrumental variable analyses 198 
Instrumental variable analyses showed no evidence for associations between B12 and hay 199 
fever: OR=1.02 (95% CI: 0.98, 1.05), asthma: OR=0.99 (95% CI: 0.95, 1.04), allergic 200 
sensitization: OR=1.02 (95% CI: 0.74, 1.40), and a 10.0% (95% CI: -9.6%, 29.6%) change in 201 
serum IgE per 100 pg/ml B12. Similarly there was no evidence for association between folate 202 
and hay fever: OR=0.74 (95% CI: 0.45, 1.21), asthma: OR=0.80 (95% CI: 0.43, 1.49), 203 
allergic sensitization: OR=1.92 (95% CI: 0.11, 33.45). There was evidence of a positive 204 
association between folate and serum IgE with a 2.00% (95% CI: 0.43%, 3.58%) change in 205 
serum IgE per 0.1 ng/ml serum folate. We found no evidence of pleiotropy for B12 and 206 
binary outcomes, as indicated by the MR Egger intercept test. However, the MR Egger 207 
analyses were underpowered which was reflected by the large confidence intervals for the 208 
odds ratios (27). 209 
 210 
Discussion 211 
In a Mendelian randomization meta-analysis of nine population-based studies, we found that 212 
genetically determined higher serum vitamin B12 and folate levels were not associated with 213 
hay fever, asthma, or allergic sensitization. In contrast, a genetically determined higher folate 214 
level was positively associated with changes in total serum total IgE. Thus, beside a possible 215 
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 causal role of folate level on serum total IgE, our results do not support the conclusion that 216 
high or low vitamin B12 and folate status are causally related to the examined allergy and 217 
asthma phenotypes. MR-studies in general need large sample sized. Of note in the current 218 
study, the analyses of allergic sensitization and serum total IgE included substantially fewer 219 
participants than the other outcomes and may have been underpowered. 220 
 Previous studies have mainly focused on a possible detrimental effect of high 221 
folate levels and folate supplementation in pregnancy on offspring risk of allergy and asthma 222 
(28-35). In a systematic review of prospective cohort studies, Brown et al. concluded that the 223 
investigations of the association between maternal folate levels and risk of childhood asthma 224 
and allergic disease reported conflicting results (36). Some of the studies found that higher 225 
maternal levels of serum folate levels associated with a slightly increased risk of allergic 226 
disease, while most of the included studies found no association (36). Another systematic 227 
review that also included a meta-analysis, Crider et al. found no association between maternal 228 
folic acid supplementation before and in the first trimester of pregnancy and risk of asthma in 229 
the offspring (32).  230 
 In a birth cohort of 2001 children, Van der Valk et al. found that folate and 231 
vitamin B12 levels at birth did not affect asthma- and eczema-associated outcomes up to the 232 
age of 6 years (33). Matsui et al. found that serum folate levels were inversely associated with 233 
atopy, wheeze and high total IgE levels in a cross-sectional study of 8,083 children two years 234 
of age and older (37). In a high-risk birth cohort, Okupa et al. found that higher serum folate 235 
levels in the early childhood were significantly associated with higher incidence of both food 236 
and aeroallergen sensitization (38). Blatter et al. found that folate deficiency was associated 237 
with higher risk of atopy and severe asthma exacerbations in 582 Puerto Rican children aged 238 
6-14 years (39). In comparison, in a population-based study of 6,784 adults aged 30-60 years, 239 
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 Thuesen et al. found that folate deficiency was associated with self-reported asthma and 240 
attacks of shortness of breath but not allergic sensitization. Folate deficiency at baseline was 241 
not associated with changes in these outcomes over a five-year follow-up period (24).  242 
The validity of an IV is dependent on three assumptions referred to as 243 
‘relevance’, ‘independence’, and ‘exclusion’ where the first can be verified but the two latter 244 
can only be falsified (12). The assumptions behind the approach of estimating the magnitude 245 
of the causal effect are even more stringent compared to methods to investigate whether a 246 
causal association exists (12). Regarding relevance, the IVs were constructed by SNPs with 247 
previously published associations (in populations different from those included here) with 248 
B12 or folate. In general, the strengths of the instruments in our samples were acceptable, and 249 
in additional analyses, the exclusion of the few SNPs with less favourable F-values led to 250 
similar results. The risk of violation of this assumption is also reduced when using 251 
biologically plausible SNPs (23).  252 
Testing the independence assumption, we performed MR Egger tests on B12 253 
and binary outcomes to remove the bias due to pleiotropy where the genetic marker has 254 
diverse biological functions (40). In addition, Grarup et al. have evaluated possible 255 
pleiotropic effects of the included B12 and folate associated SNPs by screening their 256 
phenotype database that holds data on most of the common diseases and risk factors (23). 257 
The FUT2 SNP was strongly associated with serum levels of alkaline phosphatase and 258 
psoriasis as previously reported (23). Also, they found an association between 259 
the FUT6 variant and abdominal aortic aneurysm and between the folate-associated variant 260 
in MTHFR and thoracic aortic aneurysm (23). However, these associations are not likely to 261 
affect the risk of allergic disease. Grarup et al. also tested that the SNPs were not in linkage 262 
disequilibrium. 263 
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 The minimal impact on the results of adjusting for potential confounders 264 
suggests that the exclusion assumption was not violated. Further substantiating the results in 265 
general, a number of supplementary analyses in different samples (e.g., in UK Biobank sub-266 
samples), adjusting for other possible confounders, using different scores and weighting, and 267 
in studies with ≥12 SNPs or with F-values ≥10, left the results largely unchanged.  268 
The proportion of participants with hay fever, asthma, and allergic sensitization 269 
varied across studies, and this is likely to reflect true differences in disease prevalence for 270 
different age groups, period of examination, and methodology. The techniques and assays 271 
used for B12, folate and IgE measurements varied across the studies and may have influence 272 
the associations described. Serum levels of vitamin B12 and folate were only measured in 273 
four out of the nine studies included which is why we could only verify the SNP/biomarker 274 
associations in these studies. In addition, due to the smaller study sample with data on B12 275 
and folate, the IV-estimates had less precision resulting in wider 95% CIs for the estimated 276 
effects sizes. Similarly we had much less data on allergic sensitization compared to hay fever 277 
and asthma resulting in lower precision for effects on allergic sensitization. Of note, the use 278 
of the two-sample MR approach in the instrumental variable analyses caused a substantial 279 
loss of power because we needed two samples with no overlap, thereby reducing the sample 280 
sizes in the SNP-exposure and SNP outcome analyses (12). 281 
 In conclusion, we found that known genetic markers of serum vitamin B12 and 282 
folate concentrations were not associated with hay fever, asthma, and allergic sensitization 283 
(specific IgE to inhalant allergens). Genetic markers of serum folate level were positively 284 
associated with levels of serum total IgE. However, serum total IgE is a less specific 285 
biomarker of allergic respiratory disease than serum specific IgE. Hence, results of this 286 
Mendelian randomization meta-analysis do not support that high or low serum vitamin B12 287 
 13 
 and folate concentrations are causally related to the risk of hay fever, asthma, or allergic 288 
sensitization in adults. 289 
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 Figure Legends 
Figure 1. Meta-analyses of age- and sex-adjusted associations between measured and genetically determined 
higher levels of vitamin B12 and hay fever, asthma and allergic sensitization according to ordinary least square 
(OLS), instrumental variable and Egger regression analysis.  
N is the total number participants in each analysis. The studies providing data for each analysis were for OLS: hay fever 
(Health2006, Health2008, and SHIP TREND), asthma (Health2006, Health2008, Inter99, and SHIP TREND), and 
allergic sensitization (Health2006, Health2008, and Inter99), and for IV and Egger regression: hay fever (all nine), 
asthma (all nine) and allergic sensitization (all but SHIP and UK Biobank). 
 
Figure 2. Meta-analyses of age- and sex-adjusted associations between measured and genetically determined 
higher serum level of folate and hay fever, asthma and allergic sensitization according to ordinary least square 
and instrumental variable analysis. 
N is the total number participants in each analysis. The studies providing data for each analysis were for the 
observational analyses: hay fever (Health2006, Health2008, and SHIP TREND), asthma (Health2006, Health2008, 
Inter99, and SHIP TREND), and allergic sensitization (Health2006, Health2008, and Inter99), and for instrumental 
variable analyses: hay fever (all nine), asthma (all nine) and allergic sensitization (all but SHIP and UK Biobank). 
 
Figure 3. Meta-analyses of age- and sex-adjusted associations between measured and genetically determined 
higher serum levels of B12 and folate, and changes in serum total IgE level in % according to ordinary least 
square and instrumental variable analysis. 
N is the total number participants in each analysis. The studies providing data for each analysis were for both B12 and 
folate: OLS (Inter99) and IV (all but Monica10 and UK Biobank). 
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Table 1. Descriptive statistics of the study populations. 
 N % (N) Median (IQR) 
 Total Males Hay fever Asthma Allergic sensitization Age, years 
Vitamin B12, 
pg/ml Folate, ng/ml 
Serum total 
IgE, IU/ml 
Allergy98 1,169 45.8 (536) 26.5 (310) 11.0 (128) 37.9 (443) 38 (29, 51) - - 37.2 (12.2, 106) 
Monica10 2,079 49.6 (1,031) 11.1 (231) 6.7 (139) 18.3 (381) 52 (42, 62) - - - 
Health2006 2,362 46.1 (1,088) 17.8 (420) 10.2 (242) 23.6 (558) 50 (40, 60) 382 (309, 467) 15.4 (10.7, 26.1) - 
Health2008 622 44.7 (278) 21.2 (132) 12.2 (76) 27.6 (172) 47 (40, 54) 544 (447, 663) 4.1 (3, 6) - 
Inter99 4,565 48.4 (2,209) - 8.4 (383) 33.6 (1,535) 45 (40, 50) 291 (239, 359) 7.3 (5.9, 10.0) 28.2 (10.6, 76.8) 
The 1936 Cohort 593 47.4 (281) 9.8 (58) 6.8 (40) 14.3 (85) 60 (60, 61) - - - 
UK Biobank 146,072 47.0 (68,662) 22.4 (32,752) 12.3 (18,010) - 58 (51, 63) - - - 
SHIP 4,291 49.1 (2,107) 7.9 (341) 0.9 (38) - 50 (36, 63) - - 36.4 (16.7, 103)* 
SHIP TREND 983 43.7 (430) 14.3 (141) 4.2 (41) - 50 (40,61) 435 (332, 551) 9.4 (6.5, 13.2) - 
Abbreviations: Inter99, Intervention 1999; IgE, immunoglobulin E; IQR, interquartile range; Monica, Monitoring of trends and determinants in Cardiovascular 
Diseases; SHIP, Study of Health in Pomerania; UK Biobank, United Kingdom Biobank. 
* Only measured in 3,450 persons. 
Table 2. Individual SNPs associated with serum levels of vitamin B12 or folate (14) 
SNP Alleles*(effect/other) Effect allele 
frequency 
Weights** Location/nearest 
gene 
B12-associated     
rs3742801 T/C 0.294 0.045 ABCD4 
rs602662 A/G 0.596 0.16 FUT2 
rs2336573 T/C 0.031 0.32 CD320 
rs1131603 C/T 0.055 0.19 TCN2 
rs1801222 G/A 0.593 0.11 CUBN 
rs34324219 C/A 0.881 0.21 TCN1 
rs41281112 C/T 0.948 0.17 CLYBL 
rs2270655 G/C 0.941 0.066 MMAA 
rs1141321***  C/T 0.627 0.061 MUT 
rs778805 A/G 0.254 0.046 FUT6 
rs1047891 C/A 0.038 0.038 CPS1 
Folate-associated     
rs1801133 G/A 0.668 0.096 MTHFR 
rs652197 C/T 0.179 0.069 FOLR3 
* The effect allele is the allele associated with increased serum B12 or folate levels, respectively. The 
numbers are from previously published data. **From an Icelandic sample (14). ***rs4267943 is proxy. 
 



